ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BHARATHY SUNDARAM MD

Neurology

3,487

$1.22M

364
202 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 28%

$348
Average prescription price

Avg: $218

SAMI ABOUMATAR M.D.

Neurology

3,478

$721K

218
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 28%

$207
Average prescription price

Avg: $218

TOAN VU M.D.

Neurology

3,461

$377K

390
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$109
Average prescription price

Avg: $218

JOEL FREITAG MD

Neurology

3,452

$702K

354
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 28%

$203
Average prescription price

Avg: $218

KANDASAMI SENTHILKUMAR M.D.

Neurology

3,431

$936K

453
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 28%

$273
Average prescription price

Avg: $218

RONALD STOTZ MD

Neurology

3,374

$317K

218
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$94
Average prescription price

Avg: $218

MARIANNA KARPINOS MD

Neurology

3,297

$385K

463
394 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$117
Average prescription price

Avg: $218

MICHAEL NEWMARK MD

Neurology

3,222

$404K

422
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$125
Average prescription price

Avg: $218

CHERRY MATHEW MD

Neurology

3,201

$364K

334
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$114
Average prescription price

Avg: $218

JOSEPH CAMERO MD

Neurology

3,198

$205K

269
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$64
Average prescription price

Avg: $218

JOOHI JIMENEZ-SHAHED M.D.

Neurology

3,159

$2.61M

324
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$828
Average prescription price

Avg: $218

IRFAN LALANI M.D.

Neurology

3,156

$257K

430
317 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$81
Average prescription price

Avg: $218

DAVID WENZEL M.D.

Neurology

3,135

$859K

419
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$274
Average prescription price

Avg: $218

ROBERTO NIETO M.D.

Neurology

3,093

$554K

298
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 28%

$179
Average prescription price

Avg: $218

MICHAEL HUMMER

Neurology

3,080

$493K

202
94 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$160
Average prescription price

Avg: $218

BLAKE O'LAVIN M.D.

Neurology

3,076

$732K

339
185 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$238
Average prescription price

Avg: $218

SCOTT HALL M.D.

Neurology

3,059

$592K

344
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$193
Average prescription price

Avg: $218

CHARLECE HUGHES D.O.

Neurology

3,045

$709K

322
234 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$233
Average prescription price

Avg: $218

GANANA TESFA M.D.

Neurology

3,031

$568K

340
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$187
Average prescription price

Avg: $218

RICARDO PARDO MD

Neurology

3,020

$672K

228
142 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 28%

$222
Average prescription price

Avg: $218

CARL BROWN D.O.

Neurology

3,015

$727K

290
177 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$241
Average prescription price

Avg: $218

LESTER COLLINS M.D. P.C.

Neurology

2,963

$525K

286
159 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$177
Average prescription price

Avg: $218

VASISHTA PATEL M.D.

Neurology

2,958

$272K

229
169 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$92
Average prescription price

Avg: $218

KHANH NGUYEN M.D.

Neurology

2,932

$302K

248
176 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$103
Average prescription price

Avg: $218

LINCOLN CHIN M.D.

Neurology

2,927

$987K

367
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$337
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank